Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine

• Published in: Applied and environmental microbiology 2016-07, Vol.82 (14), p.4264-4278
• Main Authors: Coats, Stephen R, Hashim, Ahmed, Paramonov, Nikolay A, To, Thao T, Curtis, Michael A, Darveau, Richard P
• Format: Article
• Language: English
• Subjects: Animals; Bacteroidetes - immunology; Binding sites; Cardiolipins - metabolism; Digestive system; Enterobacteriaceae - immunology; Genetics and Molecular Biology; Homeostasis; Immunologic Factors - metabolism; Intestines - immunology; Intestines - microbiology; Lipids; Lipopolysaccharides - immunology; Mice; Mitochondria; Proteins; Spotlight; Toll-Like Receptor 4 - antagonists & inhibitors
• ISSN: 0099-2240; 1098-5336
• DOI: 10.1128/AEM.00463-16

Intestinal homeostasis mechanisms must protect the host intestinal tissue from endogenous lipopolysaccharides (LPSs) produced by the intestinal microbiota. In this report, we demonstrate that murine intestinal fecal lipids effectively block Toll-like receptor 4 (TLR4) responses to naturally occurring Bacteroidetes sp. LPS. Cardiolipin (CL) represents a significant proportion of the total intestinal and fecal lipids and, furthermore, potently antagonizes TLR4 activation by reducing LPS binding at the lipopolysaccharide binding protein (LBP), CD14, and MD-2 steps of the TLR4 signaling pathway. It is further demonstrated that intestinal lipids and CL are less effective at neutralizing more potent Enterobacteriaceae-type LPS, which is enriched in feces obtained from mice with dextran sodium sulfate (DSS)-treated inflammatory bowel disease. The selective inhibition of naturally occurring LPS structures by intestinal lipids may represent a novel homeostasis mechanism that blocks LPS activation in response to symbiotic but not dysbiotic microbial communities. The guts of animals harbor a variety of Gram-negative bacteria associated with both states of intestinal health and states of disease. Environmental factors, such as dietary habits, can drive the microbial composition of the host animal's intestinal bacterial community toward a more pathogenic state. Both beneficial and harmful Gram-negative bacteria are capable of eliciting potentially damaging inflammatory responses from the host intestinal tissues via a lipopolysaccharide (LPS)-dependent pathway. Physical mucosal barriers and antibodies produced by the intestinal immune system protect against the undesired inflammatory effects of LPS, although it is unknown why some bacteria are more effective at overcoming the protective barriers than others. This report describes the discovery of a lipid-type protective barrier in the intestine that reduces the deleterious effects of LPSs from beneficial bacteria but is less effective in dampening the inflammatory effects of LPSs from harmful bacteria, providing a novel mechanistic insight into inflammatory intestinal disorders.